All Stories

  1. Data from Body Weight Correlates with Molecular Variances in Patients with Cancer
  2. Data from Body Weight Correlates with Molecular Variances in Patients with Cancer
  3. Supplementary Data from Body Weight Correlates with Molecular Variances in Patients with Cancer
  4. Supplementary Data from Body Weight Correlates with Molecular Variances in Patients with Cancer
  5. Body Weight Correlates with Molecular Variances in Cancer Patients
  6. Protein Arginine Methyltransferase 1 in the Generation of Immune Megakaryocytes: A Perspective Review
  7. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus
  8. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia
  9. Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
  10. Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1
  11. The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis inducing ligand
  12. The AS‐RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation
  13. Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
  14. Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis
  15. Exploration of Cyanine Compounds as Selective Inhibitors of Protein Arginine Methyltransferases: Synthesis and Biological Evaluation
  16. DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia
  17. Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
  18. Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
  19. PRMT4 Blocks Myeloid Differentiation by Assembling a Methyl-RUNX1-Dependent Repressor Complex
  20. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
  21. Akt Phosphorylates the Transcriptional Repressor Bmi1 to Block Its Effects on the Tumor-Suppressing Ink4a-Arf Locus
  22. ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
  23. PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential
  24. The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations
  25. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
  26. The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
  27. Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
  28. The Mef/Elf4 Transcription Factor Fine Tunes the DNA Damage Response
  29. JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
  30. Depletion of L3MBTL1 promotes the erythroid differentiation of human hematopoietic progenitor cells: possible role in 20q- polycythemia vera
  31. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity
  32. The Epidemiology of Hantavirus Infections
  33. Figure 5—figure supplement 1. RBM15 binding to pre-mRNA of genes known important for hematopoiesis.
  34. Figure 1—figure supplement 4. RBM15 methylation status is further confirmed by a methyl-RBM15 antibody.
  35. Figure 4—figure supplement 2. RBM15 protein levels in MEG-01 cell lines expressing two short hairpin RNA constructs against RBM15 by western blots.
  36. Figure 5—source data 1. Identification of RNAs associated with RBM15 by RNA immunoprecipitation assay with anti-RBM15 antibody.
  37. Supplementary file 2. shRNA sequences for knocking down CNOT4 and RBM15 genes in human cells.
  38. Figure 7—source data 1. Mass spectrometry analysis of RBM15-associated proteins.
  39. Figure 6. Methylation of RBM15 controls alternative splicing of genes (RUNX1, GATA1 and c-MPL) important for MK differentiation.
  40. Figure 3—figure supplement 1. Purified proteins used in vitro methylation and ubiquitylation assays.